Roche's Xeloda Medicare Part B Reimbursement Raised To 90% Of AWP

Centers for Medicare & Medicaid Services raises Xeloda's reimbursement rate from 85% of AWP based on data submitted by Roche. CMS also corrects payment allowance for the company's CellCept.